Retrospective Study
Copyright ©The Author(s) 2020.
World J Clin Oncol. Dec 24, 2020; 11(12): 1018-1028
Published online Dec 24, 2020. doi: 10.5306/wjco.v11.i12.1018
Table 1 Baseline characteristics of breast cancer patients
Variables
Levels
Total, n %
Agemean ± SD48.28 ± 11.83
RegionPunjab88 (88.0%)
Khyber Pakhtunkhwa7.0 (7.0%)
Kashmir3.0 (3.0%)
Sindh2.0 (2.0%)
HistologyDuctal91 (91.0%)
Others9.0 (9.0%)
GradeII35 (35.0%)
III56 (56.0%)
UNK09 (9.0%)
Tumor sizeT17.0 (7.0%)
T2/T357 (57.0%)
UNK36 (36.0%)
NodesNegative37 (37.0%)
Positive50 (50.0%)
UNK13 (13.0%)
MetastasisNegative38 (38.0%)
Positive49 (49.0%)
UNK13 (13.0%)
Estrogen receptorNegative69 (69.0%)
Positive31 (31.0%)
Progesterone receptorNegative74 (74.0%)
Positive26 (26.0%)
HER2 statusNegative74 (74.0%)
Positive26 (26.0%)
TNBCNo51 (51.0%)
Yes49 (49.0%)
StatusAlive50 (50.0%)
Death35 (35.0%)
Lost to follow-up15 (15.0%)
FOXP3Negative75 (75.0%)
Positive25 (25.0%)
IDO scoreLow24 (24.0%)
Medium27 (27.0%)
High49 (49.0%)